Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients

Circulation: Cardiovascular Imaging

Volumn 4, Issue 3, 2011, Pages 304-311

  Salemi, Vera M C ^a   Rochitte, Carlos E ^b   Shiozaki, Afonso A ^b   Andrade, Joalbo M ^b   Parga, José R ^b   De Ávila, Luiz F ^b   Benvenuti, Luiz A ^c   Cestari, Ismar N ^d   Picard, Michael H ^e,f   Kim, Raymond J ^g   Mady, Charles ^a  

^a Cardiomyopathy Unit   (Brazil)

^b Magnetic Resonance Section   (Brazil)

^c Laboratory of Pathology   (Brazil)

^d Biomedical Technology Center   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endomyocardial fibrosis; Gadolinium; Heart failure; Magnetic resonance imaging; Myocardial cardiomyopathy disease; Prognosis; Restrictive cardiomyopathy

Indexed keywords

GADOLINIUM; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; HUMAN; IMAGING SYSTEM; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AGED; HEART STROKE VOLUME; HEART VENTRICLE; IMAGE PROCESSING; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY;

ADULT; AGED; CONTRAST MEDIA; ENDOMYOCARDIAL FIBROSIS; FEMALE; GADOLINIUM DTPA; HEART FAILURE; HEART VENTRICLES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PROGNOSIS; STROKE VOLUME;

EID: 80051726731     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.110.950675     Document Type: Article

References (26)

1. Mocumbi AO, Yacoub S, Yacoub MH. Neglected tropical cardiomyopathies, II: Endomyocardial fibrosis: Myocardial disease. Heart. 2008;94: 384-390. (Pubitemid 351303435)
2. Salemi VM, Leite JJ, Picard MH, Oliveira LM, Reis SF, Pena JL, Mady C. Echocardiographic predictors of functional capacity in endomyocardial fibrosis patients. Eur J Echocardiogr. 2009;10:400-405.
3. de Oliveira SA, Pereira Barreto AC, Mady C, Dallan LA, da Luz PL, Jatene AD, Pileggi F. Surgical treatment of endomyocardial fibrosis: A new approach. J Am Coll Cardiol. 1990;16:1246-1251. (Pubitemid 20378479)
4. Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med. 2008;359:43-49. (Pubitemid 351931095)
5. Sliwa K, Mocumbi AO. Forgotten cardiovascular diseases in Africa. Clin Res Cardiol. 2010;99:65-74.
6. Niino T, Shiono M, Yamamoto T, Inoue T, Hirose H, Saito A, Funahasi M, Negishi N, Sezai Y, Honma T, Nemoto N. A case of left ventricular endomyocardial fibrosis. Ann Thorac Cardiovasc Surg. 2002;8:173-176.
7. Salemi VM, Rochitte CE, Lemos P, Benvenuti LA, Pita CG, Mady C. Long-term survival of a patient with isolated noncompaction of the ventricular myocardium. J Am Soc Echocardiogr. 2006;19:354.e1-354.e3.
8. Alipour M, Tarbiat C, Nazarian I. Right ventricular endomyocardial fibrosis simulating Ebstein's anomaly. Am Heart J. 1980;100:859-865. (Pubitemid 11198879)
9. Barretto AC, da Luz PL, de Oliveira SA, Stolf NA, Mady C, Bellotti G, Jatene AD, Pileggi F. Determinants of survival in endomyocardial fibrosis. Circulation. 1989;80:I177-I182. (Pubitemid 19229185)
10. Barretto AC, Bellotti G, Higuchi Mde L, Stolf NA, Dauar D, Mady C, Arteaga-Fernańdez E, Lopes EA, Pileggi F. Endomyocardial biopsy of the right ventricle in patients with endomyocardial fibrosis. Arq Bras Cardiol. 1986;46:19-21.
11. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
12. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of nonischaemic cardiomyopathies. Eur Heart J. 2005;26:1461-1474. (Pubitemid 41373486)
13. Salemi VM, Rochitte CE, Barbosa MM, Mady C. Images in cardiology: Clinical and echocardiographic dissociation in a patient with right ventricular endomyocardial fibrosis. Heart. 2005;91:1399. (Pubitemid 41531807)
14. Senra T, Shiozaki AA, Salemi VM, Rochitte CE. Delayed enhancement by multidetector computed tomography in endomyocardial fibrosis. Eur Heart J. 2008;29:347. (Pubitemid 351197743)
15. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, Kalil-Filho R, Mady C, Meneghetti JC, Lima JA, Ramires JA. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: A marker of disease severity. J Am Coll Cardiol. 2005; 46:1553-1558. (Pubitemid 41446195)
16. Estornell J, Lopez MP, Dicenta F, Igual B, Martinez V, Sonlleva A. Usefulness of magnetic resonance imaging in the assessment of endomyocardial disease. Rev Esp Cardiol. 2003;56:321-324. (Pubitemid 36527255)
17. Cury RC, Abbara S, Sandoval LJ, Houser S, Brady TJ, Palacios IF. Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging. Circulation. 2005;111:e115-e117.
18. Barretto AC, Mady C, Nussbacher A, Ianni BM, Oliveira SA, Jatene A, Ramires JA. Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis. Int J Cardiol. 1998;67:19-25. (Pubitemid 28559242)
19. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson. 2005;7:775-782. (Pubitemid 41770055)
20. Mollet NR, Dymarkowski S, Volders W, Wathiong J, Herbots L, Rademakers FE, Bogaert J. Visualization of ventricular thrombi with contrastenhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation. 2002;106:2873-2876. (Pubitemid 35424733)
21. Paydarfar D, Krieger D, Dib N, Blair RH, Pastore JO, Stetz JJ Jr, Symes JF. In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: Distinct features of subacute thrombi. Cardiology. 2001;95:40-47. (Pubitemid 32506960)
22. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932-938. (Pubitemid 26292843)
23. Acquatella H, Schiller NB, Puigbo JJ, Gomez-Mancebo JR, Suarez C, Acquatella G. Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia: A clinical and pathologic study. Circulation. 1983;67:1219-1226. (Pubitemid 13105343)
24. Barretto AC, Pileggi F. Endomyocardial fibrosis: 100 cases, 10 years' experience. Arq Bras Cardiol. 1988;51:117-120.
25. Mady C, Barretto AC, Oliveira SA, Stolf N, Bellotti G, Pileggi F. Evolution of the endocardial fibrotic process in endomyocardial fibrosis. Am J Cardiol. 1991;68:402-403.
26. Moraes CR, Buffolo E, Moraes Neto F, Rodrigues JV, Gomes CA, Branco JN, Aguiar L. Recurrence of fibrosis after endomyocardial fibrosis surgery. Arq Bras Cardiol. 1996;67:297-299.